We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Alderley Park’s ApconiX Acheives Five-Fold Turnover Boost Via Pharma Sector Demand for Drug Safety Expertise

Product News   Dec 07, 2017

 
Alderley Park’s ApconiX Acheives Five-Fold Turnover Boost Via Pharma Sector Demand for Drug Safety Expertise
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Porvair Reports Ovarian Cancer Project Shows Promise

Product News

Porvair Sciences reports it has agreed with its collaborative partners to make additional investment in the CEAT project.

READ MORE

InSphero Strengthens Scientific Advisory Board To Advance Drug Discovery and Safety Solutions

Product News

InSphero AG, today announced the strengthening of its Scientific Advisory Board (SAB).

READ MORE

BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of BV100

Product News

BioVersys has reached a major milestone by entering clinical development with the start of Phase 1 testing of BV100 in healthy volunteers.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE